Financial News
Articles published by Edgewise Therapeutics
![](https://mms.businesswire.com/media/20250122879951/en/2310269/22/Edgewise_Logo_RGB.jpg)
Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage Clinical Development
January 22, 2025
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20250113992573/en/2310269/22/Edgewise_Logo_RGB.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20250107119700/en/2310269/22/Edgewise_Logo_RGB.jpg)
Edgewise Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13, 2025
January 07, 2025
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20241216264915/en/2310269/22/Edgewise_Logo_RGB.jpg)
![](https://mms.businesswire.com/media/20241205281873/en/2310269/22/Edgewise_Logo_RGB.jpg)
Edgewise Provides Statement Regarding Company’s Relationship with Dr. Han Phan at Rare Disease Research
December 05, 2024
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20241126273809/en/2310262/22/Edgewise_Logo_RGB.jpg)
Edgewise Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference on December 3, 2024
November 26, 2024
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20241107168709/en/2296583/22/Edgewise_Logo_RGB.jpg)
Edgewise Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
November 07, 2024
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20241001999394/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240919115598/en/2247555/5/Edgewise.jpg)
![](https://mms.businesswire.com/media/20240917581066/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20240808684829/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 08, 2024
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20240510618620/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240509444818/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240507270038/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20240506327325/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240423844146/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240415221564/en/2098548/5/NSAA_stabilized_with_sevasemten_treatement.jpg)
![](https://mms.businesswire.com/media/20240328046868/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240327502516/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240305698537/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240228531069/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240222982169/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240213462472/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20240118598176/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Announces Pricing of $240 Million Underwritten Offering of Common Stock
January 19, 2024
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20240109064780/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20231219829381/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024
December 19, 2023
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20231218918378/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20231130724778/en/1382019/5/Edgewise-Logo_FINAL.jpg)
![](https://mms.businesswire.com/media/20231109421952/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights
November 09, 2023
Via Business Wire
Tickers
EWTX
![](https://mms.businesswire.com/media/20231108004645/en/1382019/5/Edgewise-Logo_FINAL.jpg)
Edgewise Therapeutics to Present at Upcoming Investor Conferences
November 08, 2023
Via Business Wire
Tickers
EWTX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.